1,720,956 research outputs found
Significance of early screening for diabetic retinopathy in the European Union and the Republic of Croatia
No full textDijabetička retinopatija (DR) je česta kronična mikrovaskularna komplikacija šećerne bolesti. DR dovodi do postupnog gubitka vida i najčešći je uzrok sljepoće u EU. U proliferacijskoj DR su prisutne neovaskularizacije i vitrealna hemoragija. U dijagnostici se koriste oftalmoskopija, OCT, FA, digitalna retinografija i OCTA. U liječenju se najčešće koriste anti-angiogena i laserska terapija. U probiru za DR zlatnim standardom se smatra retinalna fotografija koja omogućuje pohranjivanje slika na računalo. Smatra se da je najbolji interval između očnih pregleda jedna ili dvije godine. U probir je bitno uvesti digitalne tehnologije i umjetnu inteligenciju. U Švedskoj postoji probir bolesnika s DR-om na lokalnoj razini. Mađarska je osmislila program za poboljšanje zdravlja osoba sa šećernom bolešću pri čemu se koristi mobilni kombi s digitalnom retinalnom kamerom. U Irskoj se koristi biomikroskop u sklopu probira. Danska je uspostavila Registar za DR nazvan Diabase koji automatski elektronički registrira podatke pregleda. U Portugalu 5 regija zasebno provodi program probira. U Finskoj i Norveškoj uvedeni su projekti telemedicine kojima se olakšava dostupnost probiru. Slovenija je uvela probir bolesnika s DR-om od 2010. godine. Engleska provodi nacionalni program probira od 2004. godine. Škotska je uvela nacionalni program probira od 2003. godine i automatizirani sustav za očitanje slika digitalne retinografije. Probir bolesnika s DR-om ima ključnu ulogu u prevenciji i sprječavanju progresije DR-a čime se smanjuje učestalost sljepoće u osoba sa šećernom bolešću. Cilj ovog rada je približiti mogućnosti i prednosti probira DR-a široj akademskoj zajednici kako bi se doprinijelo poboljšanju zdravlja osoba sa šećernom bolešću.Diabetic retinopathy (DR) is a usual chronic microvascular complication which occurs in diabetes. DR causes gradual visual impairment and is a typical cause of sightlessness in the EU. Neovascularization and vitreal hemorrhage are present in proliferative DR. Ophthalmoscopy, OCT, FA, digital retinography and OCTA are used in diagnostics. Anti-angiogenic and laser therapy are most often used as treatment. In screening for DR, retinal photography is considered the gold standard, which allows images to be stored on a computer. It is considered that the best interval between eye examinations is one or two years. It is essential to introduce digital technologies and artificial intelligence into screening. In Sweden, there is screening for DR at the local level. Hungary has designed a program to raise life quality in patients with diabetes using a mobile van containing digital retinal camera. In Ireland, a biomicroscope is used as part of screening. Denmark has established a Registry for DR called Diabase which automatically electronically registers all examination data. In Portugal, 5 regions carry out a screening program separately. Telemedicine projects have been introduced in Finland and Norway to facilitate access to screening. Slovenia has introduced DR screening since 2010. England has been running a national screening program since 2004. Scotland has introduced a national screening program since 2003, and an automated system for reading digital retinography images has also been introduced. The screening for DR plays a crucial role in preventing and stopping the progression of DR, thereby reducing the incidence of blindness in diabetic patients. The aim of this work is to bring the possibilities and benefits of DR screening to wider academic community in order to improve the health of patients with diabetes
Significance of early screening for diabetic retinopathy in the European Union and the Republic of Croatia
No full textDijabetička retinopatija (DR) je česta kronična mikrovaskularna komplikacija šećerne bolesti. DR dovodi do postupnog gubitka vida i najčešći je uzrok sljepoće u EU. U proliferacijskoj DR su prisutne neovaskularizacije i vitrealna hemoragija. U dijagnostici se koriste oftalmoskopija, OCT, FA, digitalna retinografija i OCTA. U liječenju se najčešće koriste anti-angiogena i laserska terapija. U probiru za DR zlatnim standardom se smatra retinalna fotografija koja omogućuje pohranjivanje slika na računalo. Smatra se da je najbolji interval između očnih pregleda jedna ili dvije godine. U probir je bitno uvesti digitalne tehnologije i umjetnu inteligenciju. U Švedskoj postoji probir bolesnika s DR-om na lokalnoj razini. Mađarska je osmislila program za poboljšanje zdravlja osoba sa šećernom bolešću pri čemu se koristi mobilni kombi s digitalnom retinalnom kamerom. U Irskoj se koristi biomikroskop u sklopu probira. Danska je uspostavila Registar za DR nazvan Diabase koji automatski elektronički registrira podatke pregleda. U Portugalu 5 regija zasebno provodi program probira. U Finskoj i Norveškoj uvedeni su projekti telemedicine kojima se olakšava dostupnost probiru. Slovenija je uvela probir bolesnika s DR-om od 2010. godine. Engleska provodi nacionalni program probira od 2004. godine. Škotska je uvela nacionalni program probira od 2003. godine i automatizirani sustav za očitanje slika digitalne retinografije. Probir bolesnika s DR-om ima ključnu ulogu u prevenciji i sprječavanju progresije DR-a čime se smanjuje učestalost sljepoće u osoba sa šećernom bolešću. Cilj ovog rada je približiti mogućnosti i prednosti probira DR-a široj akademskoj zajednici kako bi se doprinijelo poboljšanju zdravlja osoba sa šećernom bolešću.Diabetic retinopathy (DR) is a usual chronic microvascular complication which occurs in diabetes. DR causes gradual visual impairment and is a typical cause of sightlessness in the EU. Neovascularization and vitreal hemorrhage are present in proliferative DR. Ophthalmoscopy, OCT, FA, digital retinography and OCTA are used in diagnostics. Anti-angiogenic and laser therapy are most often used as treatment. In screening for DR, retinal photography is considered the gold standard, which allows images to be stored on a computer. It is considered that the best interval between eye examinations is one or two years. It is essential to introduce digital technologies and artificial intelligence into screening. In Sweden, there is screening for DR at the local level. Hungary has designed a program to raise life quality in patients with diabetes using a mobile van containing digital retinal camera. In Ireland, a biomicroscope is used as part of screening. Denmark has established a Registry for DR called Diabase which automatically electronically registers all examination data. In Portugal, 5 regions carry out a screening program separately. Telemedicine projects have been introduced in Finland and Norway to facilitate access to screening. Slovenia has introduced DR screening since 2010. England has been running a national screening program since 2004. Scotland has introduced a national screening program since 2003, and an automated system for reading digital retinography images has also been introduced. The screening for DR plays a crucial role in preventing and stopping the progression of DR, thereby reducing the incidence of blindness in diabetic patients. The aim of this work is to bring the possibilities and benefits of DR screening to wider academic community in order to improve the health of patients with diabetes
Significance of early screening for diabetic retinopathy in the European Union and the Republic of Croatia
No full textDijabetička retinopatija (DR) je česta kronična mikrovaskularna komplikacija šećerne bolesti. DR dovodi do postupnog gubitka vida i najčešći je uzrok sljepoće u EU. U proliferacijskoj DR su prisutne neovaskularizacije i vitrealna hemoragija. U dijagnostici se koriste oftalmoskopija, OCT, FA, digitalna retinografija i OCTA. U liječenju se najčešće koriste anti-angiogena i laserska terapija. U probiru za DR zlatnim standardom se smatra retinalna fotografija koja omogućuje pohranjivanje slika na računalo. Smatra se da je najbolji interval između očnih pregleda jedna ili dvije godine. U probir je bitno uvesti digitalne tehnologije i umjetnu inteligenciju. U Švedskoj postoji probir bolesnika s DR-om na lokalnoj razini. Mađarska je osmislila program za poboljšanje zdravlja osoba sa šećernom bolešću pri čemu se koristi mobilni kombi s digitalnom retinalnom kamerom. U Irskoj se koristi biomikroskop u sklopu probira. Danska je uspostavila Registar za DR nazvan Diabase koji automatski elektronički registrira podatke pregleda. U Portugalu 5 regija zasebno provodi program probira. U Finskoj i Norveškoj uvedeni su projekti telemedicine kojima se olakšava dostupnost probiru. Slovenija je uvela probir bolesnika s DR-om od 2010. godine. Engleska provodi nacionalni program probira od 2004. godine. Škotska je uvela nacionalni program probira od 2003. godine i automatizirani sustav za očitanje slika digitalne retinografije. Probir bolesnika s DR-om ima ključnu ulogu u prevenciji i sprječavanju progresije DR-a čime se smanjuje učestalost sljepoće u osoba sa šećernom bolešću. Cilj ovog rada je približiti mogućnosti i prednosti probira DR-a široj akademskoj zajednici kako bi se doprinijelo poboljšanju zdravlja osoba sa šećernom bolešću.Diabetic retinopathy (DR) is a usual chronic microvascular complication which occurs in diabetes. DR causes gradual visual impairment and is a typical cause of sightlessness in the EU. Neovascularization and vitreal hemorrhage are present in proliferative DR. Ophthalmoscopy, OCT, FA, digital retinography and OCTA are used in diagnostics. Anti-angiogenic and laser therapy are most often used as treatment. In screening for DR, retinal photography is considered the gold standard, which allows images to be stored on a computer. It is considered that the best interval between eye examinations is one or two years. It is essential to introduce digital technologies and artificial intelligence into screening. In Sweden, there is screening for DR at the local level. Hungary has designed a program to raise life quality in patients with diabetes using a mobile van containing digital retinal camera. In Ireland, a biomicroscope is used as part of screening. Denmark has established a Registry for DR called Diabase which automatically electronically registers all examination data. In Portugal, 5 regions carry out a screening program separately. Telemedicine projects have been introduced in Finland and Norway to facilitate access to screening. Slovenia has introduced DR screening since 2010. England has been running a national screening program since 2004. Scotland has introduced a national screening program since 2003, and an automated system for reading digital retinography images has also been introduced. The screening for DR plays a crucial role in preventing and stopping the progression of DR, thereby reducing the incidence of blindness in diabetic patients. The aim of this work is to bring the possibilities and benefits of DR screening to wider academic community in order to improve the health of patients with diabetes
Going Beyond Counting First Authors in Author Co-citation Analysis
Full text linkThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
Variations on the Author
Full text link“Variations on the Author” discusses two of Eduardo Coutinho’s recent films (Um Dia na Vida, from 2010, and Últimas Conversas, posthumously released in 2015) and their contribution to the general question of documentary authorship. The director’s filmography is characterized by a consistent yet self-effacing form of authorial self-inscription: Coutinho often features as an interviewer that rather than express opinions propels discourses; an interviewer that is good at listening. This mode of self-inscription characterizes him as an author who is not expressive but who is nonetheless markedly present on the screen. In Um Dia na Vida, however, Coutinho is completely absent form the image, while Últimas Conversas, on the contrary, includes a confessional prologue that moves the director from the margins to the center of his films. This article examines the ways in which these works stand out in the filmography of a director who offers new insights into the notion of cinematic authorship
Appropriate Similarity Measures for Author Cocitation Analysis
Full text linkWe provide a number of new insights into the methodological discussion about author cocitation analysis. We first argue that the use of the Pearson correlation for measuring the similarity between authors’ cocitation profiles is not very satisfactory. We then discuss what kind of similarity measures may be used as an alternative to the Pearson correlation. We consider three similarity measures in particular. One is the well-known cosine. The other two similarity measures have not been used before in the bibliometric literature. Finally, we show by means of an example that our findings have a high practical relevance.information science;Pearson correlation;cosine;similarity measure;author cocitation analysis
Dispelling the Myths Behind First-author Citation Counts
Full text linkWe conducted a full-scale evaluative citation analysis study of scholars in the XML research field to explore just how different from each other author rankings resulting from different citation counting methods actually are, and to demonstrate the capability of emerging data and tools on the Web in supporting more realistic citation counting methods. Our results contest some common arguments for the continued
use of first-author citation counts in the evaluation of scholars, such as high correlations between author rankings by first-author citation counts and other citation
counting methods, and high costs of using more realistic citation counting methods that are not well-supported by the ISI databases. It is argued that increasingly available digital full text research papers make it possible for citation analysis studies to go beyond what the ISI databases have directly supported and to employ more
sophisticated methods
koamabayili/VECTRON-author-checklist: VECTRON author checklist
No full textWe have done our best to complete the author checklist relating to the use of animals in the hut study. Note that the objective for the hut study was to evaluate the IRS treatment applications for residual efficacy against Anopheles mosquitoes, including the local An. coluzzii mosquito population. Cows were only used to attract mosquitoes into the huts and no tests were carried out directly on the cows. The author checklist is intended for use with studies where experiments are carried out on animals, which is why we have had such difficulty in completing this for the hut study, as many of the questions do not relate to how the cows were used
- …
